NCT07178197Completed
Sarcopenia in Patients With Idiopathic Pulmonary Fibrosis
Association of Sarcopenia With Quality of Life and Progression of Disease in Patients With Idiopathic Pulmonary Fibrosis
Source: ClinicalTrials.gov · Last updated 17 Sept 2025
Brief summary (registry, in English)
Sarcopenia negatively affects the prognosis of chronic diseases. However, the importance of sarcopenia in patients with idiopathic pulmonary fibrosis (IPF) has been less emphasized. The aim of the study is to determine the prevalence of sarcopenia in patients with IPF and to evaluate the impact of sarcopenia on quality of life and disease progression. This study was designed as a descriptive cross-sectional. The study included patients diagnosed with IPF. Hand dynamometry and bioelectrical impedance analysis (BIA) were used to for diagnose of sarcopenia. Pulmonary function tests, maximal inspiratory pressure (MIP), and maximal expiratory pressure (MEP) measurements were examined. The 6-minute walk distance (6MWD) and 4-meter walking speed were recorded. The St. George Respiratory Questionnaire (SGRQ) was used to assess quality of life. All patients were evaluated for progressive disease.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 60 (actual)
- First submitted
- 25 Aug 2025
- Start date
- 1 Dec 2022
- Primary completion date
- 1 Dec 2023
- Lead sponsor
- Mersin University
- Diseases
- Idiopathic pulmonary fibrosis
- NCT number
- NCT07178197
What you commit to
- Study type: Observational
- Participants enrolled: 60
- From 1 Dec 2022 to the primary completion date, 1 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of cancer within the last 5 years
- History of lung surgery
- History of neuromuscular disease
- Active pulmonary tuberculosis
- Active respiratory tract infection
- History of systemic steroid use within the past 3 months
Other
- Pregnancy
- Inability to perform pulmonary function tests
- Presence of a pacemaker
- Inability to use a hand dynamometer
Who the study is looking for
- Being over 18 years of age
- Signing the informed consent form
- Having a diagnosis of IPF for at least one month
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mersin University Faculty of Medicine Coordinator of this site? Confirm its status | Mersin | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.